Morgan Stanley (NY:MS)
All News about Morgan Stanley
Ardelyx Targets $500M Revenue This Year, Profitability by 2027 ↗
September 21, 2026
Via MarketBeat
Cognex Touts AI Vision Growth Across Data Centers, Semis and China ↗
September 21, 2026
Via MarketBeat
Topics
Artificial Intelligence
Via MarketBeat
Via MarketBeat
Aurora Innovation Targets 20 Driverless Trucks a Week as DaaS Shift Takes Shape ↗
September 20, 2026
Via MarketBeat
Topics
Artificial Intelligence
Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B ↗
September 20, 2026
Via MarketBeat
Topics
Cannabis
WW International Eyes Cash Flow Turnaround as GLP-1 Care Gains Momentum ↗
September 20, 2026
Via MarketBeat
Topics
Supply Chain
Stanley Black & Decker Targets Margin Gains as DEWALT Takes Share ↗
September 20, 2026
Via MarketBeat
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗
September 20, 2026
Via MarketBeat
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets ↗
September 20, 2026
Via MarketBeat
Topics
ETFs
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference ↗
September 20, 2026
Via MarketBeat
Topics
ETFs
Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss ↗
September 20, 2026
Via MarketBeat
Topics
Intellectual Property
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push ↗
September 20, 2026
Via MarketBeat
Via MarketBeat
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds ↗
September 19, 2026
Via MarketBeat
Topics
World Trade
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction ↗
September 19, 2026
Via MarketBeat
Via MarketBeat
Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances ↗
September 19, 2026
Via MarketBeat
Topics
Intellectual Property
BioCryst Eyes $1B Rare-Disease Future Through External Innovation ↗
September 18, 2026
Via MarketBeat
L3Harris Pivots to Execution as New CEO Targets Radio, Space Growth ↗
September 18, 2026
Via MarketBeat
BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone ↗
September 18, 2026
Via MarketBeat